GALLIUM CITRATE GA 67
LOE ApproachingNDAINJECTIONINJECTABLE
Approved
Dec 1977
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 9h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Gallium Citrate GA 67 is a radioactive diagnostic imaging agent approved in 1977 for use as an injectable tracer in nuclear medicine. It is used to detect certain infections, inflammations, and malignancies by localizing to areas of increased metabolic activity. The agent works by binding to transferrin in the bloodstream and accumulating in target tissues, allowing visualization via gamma camera imaging.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30), suggesting consolidation of commercial teams and shift toward efficient marketing rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Gallium Citrate GA 67 offers limited career growth given the approaching LOE and zero linked job postings; roles are maintenance-focused rather than expansion-focused. Career mobility is better suited for professionals seeking expertise in diagnostic radiopharmaceuticals, regulatory sustainability, or niche specialty products in nuclear medicine.
Regulatory Affairs Specialist
Worked on GALLIUM CITRATE GA 67 at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.